Post Award Information
This award is intended for junior faculty who meet the criteria for Early Stage Investigator, as defined by the National Institutes of Health (NIH). Please refer to the program Eligibility Criteria.
First Step
If you are chosen for an award, Gilead will contact you as we will need to set up a contract with your institution. You will also receive an invitation to present your research to the Scientific Review Committee, Gilead Medical Affairs colleagues, RSP Alumni, and your mentor. This presentation will always occur around one of the key conferences in Oncology Solid Tumors.
One Year
One year after the contract starts, you'll be required to submit a progress report (a template will be provided) and a financial update for the chair's review. Upon project completion, you'll need to submit a final report (template provided) along with final financial documents. Any unused funds must be refunded to Gilead Sciences.
Ongoing
As an alumnus of the program, you'll be invited to all future RSP events, which will help you build your networking skills and collaborate with your peers. You'll also be invited to join Gilead's Alumni community, a closed LinkedIn group. After the research is complete, Gilead may contact you each year to answer a few basic questions about its impact on your career and the scientific community which is important to demonstrate the value of the program.
Top FAQs
Institutional Review Board (IRB) approval is only required at the time of award disbursement. However a copy of the submission to the IRB must be submitted prior to the award.
The official start date is the date that the contract is signed by both your institution and Gilead Sciences. Award deference may be subject to country specific compliance regulations. If in doubt, please check with your institution.
In some cases, we can defer the start date of the award up to 4 months.
